MX2009008548A - Formulaciones de olopatadina para administracion nasal topica. - Google Patents

Formulaciones de olopatadina para administracion nasal topica.

Info

Publication number
MX2009008548A
MX2009008548A MX2009008548A MX2009008548A MX2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A MX 2009008548 A MX2009008548 A MX 2009008548A
Authority
MX
Mexico
Prior art keywords
nasal administration
olopatadine
topical nasal
olopatadine formulations
formulations
Prior art date
Application number
MX2009008548A
Other languages
English (en)
Inventor
Onkar N Singh
G Michael Wall
Rajni Jani
Masood A Chowhan
Wesley Wehsin Han
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MX2009008548A publication Critical patent/MX2009008548A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen formulaciones tópicas de olopatadina para el tratamiento de trastornos alérgicos o inflamatorios de la nariz; las formulaciones acuosas contienen aproximadamente 0.6% (p/v) de olopatadina.
MX2009008548A 2007-02-07 2007-02-07 Formulaciones de olopatadina para administracion nasal topica. MX2009008548A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/003285 WO2008097220A1 (en) 2007-02-07 2007-02-07 Olopatadine formulations for topical nasal administration

Publications (1)

Publication Number Publication Date
MX2009008548A true MX2009008548A (es) 2009-08-18

Family

ID=38542957

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008548A MX2009008548A (es) 2007-02-07 2007-02-07 Formulaciones de olopatadina para administracion nasal topica.

Country Status (16)

Country Link
EP (2) EP2114367B1 (es)
JP (1) JP5149308B2 (es)
KR (1) KR20100014858A (es)
CN (1) CN101621989A (es)
AU (1) AU2007346121B2 (es)
BR (1) BRPI0721255B8 (es)
CA (1) CA2677631C (es)
DK (1) DK2114367T3 (es)
ES (2) ES2557939T3 (es)
HK (1) HK1217090A1 (es)
HU (1) HUE026162T2 (es)
MX (1) MX2009008548A (es)
PL (1) PL2114367T3 (es)
PT (1) PT2114367E (es)
SI (1) SI2114367T1 (es)
WO (1) WO2008097220A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
PL2453872T3 (pl) * 2009-07-17 2013-12-31 Alcon Res Ltd Olopatadyna w postaci spreju do donosowego podawania dzieciom
KR101271925B1 (ko) * 2011-02-10 2013-06-05 비. 김 로버트 미네랄 알칼리수
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
CN103830219A (zh) * 2012-11-20 2014-06-04 深圳大佛药业有限公司 一种稳定的奥洛他定组合物
TW202133861A (zh) * 2019-12-06 2021-09-16 日商東興藥品工業股份有限公司 含有歐羅派特錠的點鼻用組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JP3662944B2 (ja) * 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
EP1250133B1 (en) * 2000-01-25 2005-03-30 Alcon Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
KR20050074577A (ko) * 2002-11-12 2005-07-18 알콘, 인코퍼레이티드 알레르기성 비염을 치료하기 위한 항­알레르기제 및스테로이드의 용도
CA2586553C (en) 2004-11-24 2015-02-10 Alcon, Inc. Nasal sprayer containing a formulation with olopatadine

Also Published As

Publication number Publication date
HUE026162T2 (en) 2016-05-30
EP2114367A1 (en) 2009-11-11
DK2114367T3 (en) 2015-12-07
EP2977042A1 (en) 2016-01-27
AU2007346121A1 (en) 2008-08-14
CA2677631A1 (en) 2008-08-14
JP5149308B2 (ja) 2013-02-20
CN101621989A (zh) 2010-01-06
ES2781090T3 (es) 2020-08-28
HK1217090A1 (zh) 2016-12-23
ES2557939T3 (es) 2016-01-29
AU2007346121B2 (en) 2012-08-23
BRPI0721255B1 (pt) 2019-08-27
KR20100014858A (ko) 2010-02-11
BRPI0721255B8 (pt) 2021-05-25
PL2114367T3 (pl) 2016-03-31
BRPI0721255A2 (pt) 2013-01-01
JP2010518075A (ja) 2010-05-27
SI2114367T1 (sl) 2016-01-29
WO2008097220A1 (en) 2008-08-14
EP2114367B1 (en) 2015-11-04
CA2677631C (en) 2014-05-13
PT2114367E (pt) 2016-02-01
EP2977042B1 (en) 2020-01-01

Similar Documents

Publication Publication Date Title
TW200626132A (en) Topical nepafenac formulations
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
MX2010004026A (es) Piperidino-dihidrotienopirimidinas sustituidas.
MX2010001242A (es) Profarmacos de canabidiol, composiciones que comprenden profarmacos de canabidiol y metodos para utilizar los mismos.
MX2010005931A (es) Profarmacos de tetrahidrocanabinol, composiciones que comprenden profarmacos de tetrahidrocanabinol y metodos para utilizar los mismos.
EA019970B8 (ru) Производные имидазолидиндиона
HK1073996A1 (en) Use of adapalene for the treatment of dermatological disorders
WO2009003199A8 (en) Nasal and ophthalmic delivery of aqueous corticosteroid solutions
EP3632444A3 (en) Topical lfa-1 antagonists for use in localized treatment of immune related disorders
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
MY183449A (en) Formulations of quinones for the treatment of ophthalmic diseases
MX352434B (es) Formulaciones topicas que tienen biodisponibilidad aumentada.
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
MY161415A (en) A homeopathic formulation
WO2009050242A3 (de) Heterocyclus-substituierte piperazino-dihydrothienopyrimidine
WO2008002621A3 (en) Benzyl-substituted quinolone m1 receptor positive allosteric modulators
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
WO2007135026A3 (de) Substituierte pteridine als therapeutika
MX2009008548A (es) Formulaciones de olopatadina para administracion nasal topica.
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration